日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Based on network pharmacology, molecular docking, and validation experiments to investigate the active components and mechanisms of action of Tibetan Medog County Citrus medica L.: In antioxidant activity

基于网络药理学、分子对接和验证实验,研究西藏墨多县香橼(Citrus medica L.)的活性成分及其抗氧化活性机制

Tian, Lin; Zom, Pema Yang; Ma, Chao

T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors

T细胞刺激疫苗增强了CD3双特异性抗体疗法在实体瘤中的应用

Middelburg, Jim; Sluijter, Marjolein; Schaap, Gaby; Göynük, Büşra; Lloyd, Katy; Ovcinnikovs, Vitalijs; Zom, Gijs G; Marijnissen, Renoud J; Groeneveldt, Christianne; Griffioen, Lisa; Sandker, Gerwin G W; Heskamp, Sandra; van der Burg, Sjoerd H; Arakelian, Tsolere; Ossendorp, Ferry; Arens, Ramon; Schuurman, Janine; Kemper, Kristel; van Hall, Thorbald

Logic-gated antibody pairs that selectively act on cells co-expressing two antigens

逻辑门控抗体对选择性地作用于同时表达两种抗原的细胞

Simone C Oostindie, Derek A Rinaldi, Gijs G Zom, Michael J Wester, Desiree Paulet, Kusai Al-Tamimi, Els van der Meijden, Jennifer R Scheick, Tessa Wilpshaar, Bart de Jong, Marloes Hoff-van den Broek, Rachel M Grattan, Janita J Oosterhoff, Julie Vignau, Sandra Verploegen, Peter Boross, Frank J Beursk

Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions

将与优化的 Toll 样受体 2 配体偶联的 HPV-16 E6 合成肽进行皮内接种,在 HPV-16 阳性(癌前)病变患者中显示出安全性和强大的 T 细胞免疫原性。

Speetjens, Frank M; Welters, Marij J P; Slingerland, Marije; van Poelgeest, Mariette I E; de Vos van Steenwijk, Peggy J; Roozen, Inge; Boekestijn, Sanne; Loof, Nikki M; Zom, Gijs G; Valentijn, A Rob P M; Krebber, Willem-Jan; Meeuwenoord, Nico J; Janssen, Catharina A H; Melief, Cornelis J M; van der Marel, Gijs A; Filippov, Dmitri V; van der Burg, Sjoerd H; Gelderblom, Hans; Ossendorp, Ferry

Finite-Size Effects on Energy Transfer between Dopants in Nanocrystals

纳米晶体中掺杂剂间能量转移的有限尺寸效应

Mark J J Mangnus, Jeffrey Zom, Tom A J Welling, Andries Meijerink, Freddy T Rabouw

Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer

Enapotamab vedotin 是一种 AXL 特异性抗体-药物偶联物,在非小细胞肺癌中表现出临床前抗肿瘤活性

Louise A Koopman, Mikkel G Terp, Gijs G Zom, Maarten L Janmaat, Kirstine Jacobsen, Elke Gresnigt-van den Heuvel, Marcel Brandhorst, Ulf Forssmann, Freddy de Bree, Nora Pencheva, Andreas Lingnau, Maria A Zipeto, Paul Whi Parren, Esther Cw Breij, Henrik J Ditzel

Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication

新型 TLR2 结合佐剂可增强 T 细胞反应并消除肿瘤

Gijs G Zom, Marian M J H P Willems, Selina Khan, Tetje C van der Sluis, Jan Willem Kleinovink, Marcel G M Camps, Gijsbert A van der Marel, Dmitri V Filippov, Cornelis J M Melief, Ferry Ossendorp

HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex Vivo

HBV衍生合成长肽可在体外增强慢性HBV患者的CD4+和CD8+ T细胞反应

Dou, Yingying; van Montfoort, Nadine; van den Bosch, Aniek; de Man, Robert A; Zom, Gijs G; Krebber, Willem-Jan; Melief, Cornelis J M; Buschow, Sonja I; Woltman, Andrea M

TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients

TLR2 配体合成长肽复合物有效刺激宫颈癌患者的肿瘤引流淋巴结 T 细胞

Gijs G Zom, Marij J P Welters, Nikki M Loof, Renske Goedemans, Sinéad Lougheed, Rob R P M Valentijn, Maarten L Zandvliet, Nico J Meeuwenoord, Cornelis J M Melief, Tanja D de Gruijl, Gijsbert A Van der Marel, Dmitri V Filippov, Ferry Ossendorp, Sjoerd H Van der Burg

Two in one: improving synthetic long peptide vaccines by combining antigen and adjuvant in one molecule

二合一:通过将抗原和佐剂结合在一个分子中来改进合成长肽疫苗

Zom, Gijs G; Filippov, Dmitri V; van der Marel, Gijsbert A; Overkleeft, Hermen S; Melief, Cornelis J; Ossendorp, Ferry